Clinical Trial Update: Safety and Efficacy Study of NGGT002 in cPKU Adult Subjects [Phase 1, Phase 2]

View source ↗

Summary

NGGT002 is being studied in adults with phenylketonuria in Phase 1/2 trials and is currently recruiting to evaluate safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• NGGT002

Snippet

Sponsor: NGGT (Suzhou) Biotechnology Co., Ltd. | Conditions: Phenylketonurias | Phase 1, Phase 2 | Status: RECRUITING